Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10951528rdf:typepubmed:Citationlld:pubmed
pubmed-article:10951528lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:10951528lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:10951528lifeskim:mentionsumls-concept:C0152427lld:lifeskim
pubmed-article:10951528lifeskim:mentionsumls-concept:C0265275lld:lifeskim
pubmed-article:10951528lifeskim:mentionsumls-concept:C0008633lld:lifeskim
pubmed-article:10951528lifeskim:mentionsumls-concept:C1521376lld:lifeskim
pubmed-article:10951528lifeskim:mentionsumls-concept:C0039082lld:lifeskim
pubmed-article:10951528lifeskim:mentionsumls-concept:C2828389lld:lifeskim
pubmed-article:10951528pubmed:issue8lld:pubmed
pubmed-article:10951528pubmed:dateCreated2000-11-15lld:pubmed
pubmed-article:10951528pubmed:abstractTextEllis-van Creveld syndrome (EVC) is a relatively rare, usually non-lethal, autosomal recessive skeletal dysplasia characterized by short stature, polydactyly, cardiac and renal anomalies. Linkage analysis has localized the disease gene to chromosome 4p16, with the markers at loci D4S827 and D4S3135 defining the centromeric and telomeric limits of the linked interval, respectively. There has been long-term speculation that asphyxiating thoracic dystrophy (ATD) and the short-rib polydactyly syndromes (SRP) represent the severe end of the EVC disease spectrum. We performed linkage analysis using markers from the EVC region in seven families manifesting either ATD or SRP type III. In two of the families, one segregating ATD and one SRP kindred, linkage of the phenotype to the EVC region was excluded. In the other five families linkage of the phenotype to the EVC region could not be excluded, but the families were too small for linkage to the region to be established. The exclusion of the EVC region in ATD and SRP III families suggests that locus heterogeneity exists within the short-rib dysplasia (with and without polydactyly) group of disorders.lld:pubmed
pubmed-article:10951528pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10951528pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10951528pubmed:languageenglld:pubmed
pubmed-article:10951528pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10951528pubmed:citationSubsetIMlld:pubmed
pubmed-article:10951528pubmed:statusMEDLINElld:pubmed
pubmed-article:10951528pubmed:monthAuglld:pubmed
pubmed-article:10951528pubmed:issn1018-4813lld:pubmed
pubmed-article:10951528pubmed:authorpubmed-author:RimoinD LDLlld:pubmed
pubmed-article:10951528pubmed:authorpubmed-author:WilcoxW RWRlld:pubmed
pubmed-article:10951528pubmed:authorpubmed-author:SalazarDDlld:pubmed
pubmed-article:10951528pubmed:authorpubmed-author:CohnD HDHlld:pubmed
pubmed-article:10951528pubmed:authorpubmed-author:KrakowDDlld:pubmed
pubmed-article:10951528pubmed:issnTypePrintlld:pubmed
pubmed-article:10951528pubmed:volume8lld:pubmed
pubmed-article:10951528pubmed:ownerNLMlld:pubmed
pubmed-article:10951528pubmed:authorsCompleteYlld:pubmed
pubmed-article:10951528pubmed:pagination645-8lld:pubmed
pubmed-article:10951528pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:meshHeadingpubmed-meshheading:10951528...lld:pubmed
pubmed-article:10951528pubmed:year2000lld:pubmed
pubmed-article:10951528pubmed:articleTitleExclusion of the Ellis-van Creveld region on chromosome 4p16 in some families with asphyxiating thoracic dystrophy and short-rib polydactyly syndromes.lld:pubmed
pubmed-article:10951528pubmed:affiliationAhmanson Department of Pediatrics, Steven Spielberg Pediatric Research Center, Los Angeles, CA, USA. dkrakow@xchg.peds.csmc.edulld:pubmed
pubmed-article:10951528pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10951528pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10951528lld:pubmed